Somatostatin-receptor avidity of pancreatic neuroendocrine tumor thrombus in porto-caval venous systems on 99mTc-Octreotide and posttherapeutic 177Lu-DOTA-TATE scans
A 62-year-old woman with a history of abdominal pain presented with multiple hepatic lesions and dilatation of portal, splenic and superior mesenteric veins on the magnetic resonance imaging referred for a 99mTc-octreotide scan. Accordingly, similar octreotide-avid lesions were found as well as an u...
Main Authors: | Mahasti Amoui, Reyhane Ahmadi, Mohsen Qutbi, Isa Neshandar Asli |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | World Journal of Nuclear Medicine |
Subjects: | |
Online Access: | http://www.wjnm.org/article.asp?issn=1450-1147;year=2021;volume=20;issue=3;spage=324;epage=326;aulast= |
Similar Items
-
Predictive power of the post-treatment scans after the initial or first two courses of [177Lu]-DOTA-TATE
by: Alexandre Chicheportiche, et al.
Published: (2018-12-01) -
Toxicity of a combined therapy using the mTOR-inhibitor everolimus and PRRT with [177Lu]Lu-DOTA-TATE in Lewis rats
by: Johannes Zellmer, et al.
Published: (2020-04-01) -
Prevention and Management of Hormonal Crisis during Theragnosis with LU-DOTA-TATE in Neuroendocrine Tumors. A Systematic Review and Approach Proposal
by: Maria Isabel del Olmo-García, et al.
Published: (2020-07-01) -
Standardized image quality for 68Ga-DOTA-TATE PET/CT
by: Christina P. W. Cox, et al.
Published: (2020-03-01) -
Chemotherapy-Induced Upregulation of Somatostatin Receptor-2 Increases the Uptake and Efficacy of <sup>177</sup>Lu-DOTA-Octreotate in Neuroendocrine Tumor Cells
by: Rashmi G. Shah, et al.
Published: (2021-01-01)